Smartlab Europe

News

Aurabeat, USFDA Approved Anti-Covid Class 2 Medical Device for SARS-COV-2 Disinfection Launched in India

Aurabeat, USFDA approved anti-Covid Class 2 medical device for SARS-COV-2 disinfection was launched in India. Hong Kong-based Aurabeat has developed the patented AG+ five-stage sterilization purifying technology after extensive research in the field of air filtration for over a...

Bora Pharmaceuticals Appoints Senior Vice President to Strengthen Global Sales and Marketing Function

Bora Pharmaceuticals, a leading full-service contract development and manufacturing organization (CDMO), has appointed Sally Langa as its new Global SVP Sales and Marketing to help drive the company’s continued growth and achieve its aggressive expansion plans. Bringing a wealth of...

Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine

Moderna, Inc, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Therapeutic Goods Administration (TGA) has granted provisional registration to the COVID-19 Vaccine Moderna in Australia for active immunization to prevent COVID-19 caused by SARS-CoV-2...

Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership

Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost...

Johnson & Johnson’s single-dose COVID-19 vaccine gets approval for emergency use in India

Johnson & Johnson’s (J&J) single-dose Covid-19 vaccine was on Saturday granted approval for emergency use in India. “India expands its vaccine basket. Johnson and Johnson’s single-dose Covid-19 vaccine is given approval for Emergency Use in India,” health minister Mansukh...

Inovio, Advaccine receive regulatory nod for two heterologous prime-boost trials in China using Covid-19 DNA vaccine candidate, INO-4800

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that it has received regulatory allowance for two clinical trials investigating heterologous boosting...

Seagen and RemeGen enter up to $2.6bn deal for cancer drug

Seagen and a Chinese company, RemeGen, have signed an exclusive global licencing agreement to develop and market a new HER2-targeted antibody-drug conjugate (ADC), disitamab vedotin. Merging Seagen’s drug-linker technology with RemeGen’s new HER2 antibody, disitamab vedotin selectively carries the anti-cancer...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »